Division Project 1.3
United Kingdom
To study the development of immunity to SBV by experimental infection studies in sero-positive as well as sero-negative animals of the different species.
-
Member States involved: Belgium, Germany, France, the Netherlands and the United Kingdom.
Coordinator: United Kingdom
Outcome for projects 1.1, 1.2 and 1.3:
Data on pathogenesis, viremia duration, incubation time, virus distribution, virus shedding and possible persistence of Schmallenberg virus to be used for tests on live animals, generation of vaccines as well as collection of reference materials for tests’ validation.